News

Pharmabiz37m
Health ministry invites EoI for establishing Cancer TRH to ensure quality of evidence for prevention and therapy
Shardul Nautiyal, Mumbai Monday, June 23, 2025, 08:00 Hrs [IST] ...
Pharmabiz37m
Telangana IDMA eyes growth strategies of Gujarat & Maharashtra to replicate in local pharma sector
Telangana IDMA eyes growth strategies of Gujarat & Maharashtra to replicate in local pharma sector: Peethaambaran Kunnathoor, Chennai. Monday, June 23, 2025, 08:00 Hrs [IST] Altho ...
Pharmabiz37m
Despite revision, UCPMP remains toothless: Alleges FMRAI
Even though the Central government had revised the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for the pharma industry last year, it remains toothless and statutorily unbinding, ...
Pharmabiz37m
GMP is the hygiene code in pharma production: Dr H Basavanagowdappa
The JSS Academy of Higher Education & Research (JSSAHER) vice chancellor Dr H Basavanagowdappa has pointed out that Indian pharma industry should now think of GMP as the hygiene code for manufacturing ...
Pharmabiz37m
FDI inflow into hospitals & diagnostic centres grew 4 per cent in FY25
FDI inflow into hospitals & diagnostic centres grew 4 per cent in FY25: Gireesh Babu, New Delhi Monday, June 23, 2025, 08:00 Hrs [IST] The Foreign Direct Investment (FDI) equity i ...
Pharmabiz1d
GRAIL announces positive top-line results from Galleri PATHFINDER 2 study
GRAIL announces positive top-line results from Galleri PATHFINDER 2 study: Menlo Park, California Saturday, June 21, 2025, 18:00 Hrs [IST] GRAIL, Inc, a healthcare company whose m ...
Pharmabiz1d
KARL STORZ US gets expanded indication for Solo+ Tympanostomy tube device to use in pediatric patients aged 6 to 24 months old
KARL STORZ US gets expanded indication for Solo+ Tympanostomy tube device to use in pediatric patients aged 6 to 24 months old: El Segundo, California Saturday, June 21, 2025, 17: ...
Pharmabiz1d
Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML
Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...
Pharmabiz1d
CereVasc receives Health Canada investigational testing authorization to conduct STRIDE trial to evaluate eShunt System
CereVasc receives Health Canada investigational testing authorization to conduct STRIDE trial to evaluate eShunt System: Boston Saturday, June 21, 2025, 14:00 Hrs [IST] CereVasc I ...
Pharmabiz1d
Palvella Therapeutics’ drug candidate QTORIN rapamycin receives US patent
Palvella Therapeutics’ drug candidate QTORIN rapamycin receives US patent: Wayne, Pennsylvania Saturday, June 21, 2025, 13:00 Hrs [IST] Palvella Therapeutics Inc, a clinical-sta ...
Pharmabiz1d
Sanofi & Regeneron’s Dupixent receives US FDA approval to treat patients with bullous pemphigoid
Sanofi & Regeneron’s Dupixent receives US FDA approval to treat patients with bullous pemphigoid: Paris Saturday, June 21, 2025, 12:00 Hrs [IST] The US Food and Drug Administrat ...
Pharmabiz1d
Biogen begins phase 3 paediatric study of Omaveloxolone to treat Friedreich ataxia
Biogen begins phase 3 paediatric study of Omaveloxolone to treat Friedreich ataxia: Cambridge, Mass Saturday, June 21, 2025, 11:00 Hrs [IST] Biogen Inc, a leading biotechnology co ...